There have been a number of reports, particularly on social media, suggesting that non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, could worsen symptoms of COVID-19. In response to ...
News
Suspension of Registrations to the Add-Aspirin Trial
Registrations at all UK and ROI sites will be suspended from 17:00 on Thursday 9th April. Randomisation of patients registered for the run-in period by this date can proceed as per guidance found here ...
COVID-19 pandemic: Guidance for Add-Aspirin participants
In the current pandemic situation, we know that trial participants may have concerns or questions about taking their trial treatment and attending follow-up appointments. We have provided some general ...
UK Interdisciplinary Breast Cancer Symposium 2020 - Add-Aspirin Survivorship Poster
Click here to view the poster ...
Add-Aspirin Feasibility Data Published
A pre-planned feasibility analysis (based on run-in data from 2253 participants across all tumour cohorts), suggested that aspirin is well-tolerated after radical therapy, with a low burden of toxicit ...
News and Resources